Industry News
Treating stomach ulcer bacteria could reduce stomach cancer risk
7/24/2015
Researchers have found that treatment for a common gut bacteria could have a small benefit in preventing the development of gastric cancer.
Lung cancer: final NICE guidance recommends Vargatef (nintedanib) in combination with docetaxel
7/23/2015
The National Institute for Health and Care Excellence (NICE) has issued its final Technology Appraisal Guidance recommending Vargatef® (nintedanib) in combination with docetaxel as an option...
New 'chemotherapy booster' could treat lung and pancreatic cancer
7/23/2015
A new drug that blocks cancer's escape route from chemotherapy could be used to treat deadly lung and pancreatic cancers, new research reports.
Researchers develop first genetic test to predict tumor sensitivity to radiation therapy
7/23/2015
Recent advances in the understanding of cancer have led to more personalized therapies, such as drugs that target particular proteins and tests that analyze gene expression patterns in tumors to...
Decline in cancer death rates welcome, but much more to do, says Cancer Council Australia
7/23/2015
New data released today (7/23) shows that cancer death rates in Australia are continuing to fall, but not quickly enough, according to Cancer Council Australia.
Common side effect of radiation treatment for prostate cancer
7/23/2015
Factoring in anatomy and the radiation therapy dose can help doctors predict a prostate cancer patient's risk of suffering from rectal bleeding as a side effect of therapy, and tailor treatment to...
Life-extending advanced breast cancer treatment Halaven® (eribulin) will continue to be available on the Cancer Drugs Fund.
New research from Lawson uncovers important molecule in ovarian cancer
7/23/2015
Molecule plays pivotal role in making ovarian cancer cells so lethalScientists at Lawson Health Research Institute have uncovered an important new target for ovarian cancer therapy.
Poor survival in multiple myeloma patients linked to genetic variation
7/23/2015
As part of a multi-institutional effort, researchers with Huntsman Cancer Institute at the University of Utah have found that multiple myeloma patients with a genetic variation in the gene FOPNL die...
Programming adult stem cells to treat muscular dystrophy and more by mimicking nature
7/23/2015
Stem cells hold great potential for addressing a variety of conditions from spinal cord injuries to cancer, but they can be difficult to control.